These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 27106789)

  • 1. mTORC2 mediates CXCL12-induced angiogenesis.
    Ziegler ME; Hatch MM; Wu N; Muawad SA; Hughes CC
    Angiogenesis; 2016 Jul; 19(3):359-71. PubMed ID: 27106789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial Cell mTOR Complex-2 Regulates Sprouting Angiogenesis.
    Farhan MA; Carmine-Simmen K; Lewis JD; Moore RB; Murray AG
    PLoS One; 2015; 10(8):e0135245. PubMed ID: 26295809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of endothelial cell proliferation and vascular assembly through distinct mTORC2 signaling pathways.
    Wang S; Amato KR; Song W; Youngblood V; Lee K; Boothby M; Brantley-Sieders DM; Chen J
    Mol Cell Biol; 2015 Apr; 35(7):1299-313. PubMed ID: 25582201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of CXCR4 Inhibits CXCL12-Induced Angiogenesis in HUVECs through Downregulation of the MAPK/ERK and PI3K/AKT and the Wnt/β-Catenin Pathways.
    Song ZY; Wang F; Cui SX; Qu XJ
    Cancer Invest; 2018 Jan; 36(1):10-18. PubMed ID: 29381400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor 2-blocking antibodies promote angiogenesis and induce ERK1/2 and AKT signaling via CXCR4 in endothelial cells.
    Wagner NM; Bierhansl L; Nöldge-Schomburg G; Vollmar B; Roesner JP
    Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):1943-51. PubMed ID: 23723373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EphA1 activation promotes the homing of endothelial progenitor cells to hepatocellular carcinoma for tumor neovascularization through the SDF-1/CXCR4 signaling pathway.
    Wang Y; Yu H; Shan Y; Tao C; Wu F; Yu Z; Guo P; Huang J; Li J; Zhu Q; Yu F; Song Q; Shi H; Zhou M; Chen G
    J Exp Clin Cancer Res; 2016 Apr; 35():65. PubMed ID: 27066828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100A8 and S100A9 promote endothelial cell activation through the RAGE‑mediated mammalian target of rapamycin complex 2 pathway.
    Zhong X; Xie F; Chen L; Liu Z; Wang Q
    Mol Med Rep; 2020 Dec; 22(6):5293-5303. PubMed ID: 33174028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-induced endothelial proliferation requires both mTORC1 and mTORC2.
    Li W; Petrimpol M; Molle KD; Hall MN; Battegay EJ; Humar R
    Circ Res; 2007 Jan; 100(1):79-87. PubMed ID: 17110594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGD5 regulates endothelial cell PI3 kinase-β to promote neo-angiogenesis.
    Azad AK; Farhan MA; Murray CR; Suzuki K; Eitzen G; Touret N; Moore RB; Murray AG
    FASEB J; 2022 Jan; 36(1):e22080. PubMed ID: 34882832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mTORC1 and mTORC2 are differentially engaged in the development of laser-induced CNV.
    Yang JY; Madrakhimov SB; Ahn DH; Chang HS; Jung SJ; Nah SK; Park HY; Park TK
    Cell Commun Signal; 2019 Jun; 17(1):64. PubMed ID: 31200728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mTORC2, but not mTORC1, is required for hippocampal mGluR-LTD and associated behaviors.
    Zhu PJ; Chen CJ; Mays J; Stoica L; Costa-Mattioli M
    Nat Neurosci; 2018 Jun; 21(6):799-802. PubMed ID: 29786082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenic effects of stromal cell-derived factor-1 (SDF-1/CXCL12) variants in vitro and the in vivo expressions of CXCL12 variants and CXCR4 in human critical leg ischemia.
    Ho TK; Tsui J; Xu S; Leoni P; Abraham DJ; Baker DM
    J Vasc Surg; 2010 Mar; 51(3):689-99. PubMed ID: 20206813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual inhibition of mTORC1 and mTORC2 perturbs cytoskeletal organization and impairs endothelial cell elongation.
    Tsuji-Tamura K; Ogawa M
    Biochem Biophys Res Commun; 2018 Feb; 497(1):326-331. PubMed ID: 29428724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCL12 mediates trophic interactions between endothelial and tumor cells in glioblastoma.
    Rao S; Sengupta R; Choe EJ; Woerner BM; Jackson E; Sun T; Leonard J; Piwnica-Worms D; Rubin JB
    PLoS One; 2012; 7(3):e33005. PubMed ID: 22427929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mTORC2 regulates PGE2-mediated endothelial cell survival and migration.
    Dada S; Demartines N; Dormond O
    Biochem Biophys Res Commun; 2008 Aug; 372(4):875-9. PubMed ID: 18539142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RES-529: a PI3K/AKT/mTOR pathway inhibitor that dissociates the mTORC1 and mTORC2 complexes.
    Weinberg MA
    Anticancer Drugs; 2016 Jul; 27(6):475-87. PubMed ID: 26918392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes.
    Jhanwar-Uniyal M; Gillick JL; Neil J; Tobias M; Thwing ZE; Murali R
    Adv Biol Regul; 2015 Jan; 57():64-74. PubMed ID: 25442674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The roles of chemokine CXCL12 in embryonic and brain tumor angiogenesis.
    Li M; Ransohoff RM
    Semin Cancer Biol; 2009 Apr; 19(2):111-5. PubMed ID: 19038344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGD5 Regulates VEGF Receptor-2 Coupling to PI3 Kinase and Receptor Recycling.
    Farhan MA; Azad AK; Touret N; Murray AG
    Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2301-2310. PubMed ID: 29051140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CXCL12-CXCR4 chemokine pathway: a novel axis regulates lymphangiogenesis.
    Zhuo W; Jia L; Song N; Lu XA; Ding Y; Wang X; Song X; Fu Y; Luo Y
    Clin Cancer Res; 2012 Oct; 18(19):5387-98. PubMed ID: 22932666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.